XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalent $ 6,338,871 $ 6,764,870
Accounts receivable 152,027 161,177
Deferred offering costs
Deferred expenses 18,286 20,927
Other current assets 162,955 128,337
Total current assets 6,672,139 7,075,311
Property and equipment, net 12,244 10,613
Intangible assets, net 209,311 221,623
Other assets 95,000 90,000
Total assets 6,988,694 7,397,547
Current liabilities:    
Accounts payable 1,037,288 856,925
Accrued liabilities 637,025 775,857
Insurance reserve 370,461 348,442
Deferred revenue 71,875 53,764
Related party advances 9,629 9,629
Total current liabilities 2,126,278 2,044,617
Total liabilities 2,126,278 2,044,617
Commitments and contingencies (Note 3)
Stockholders' equity:    
Preferred stock, 15,000,000 shares authorized, par value $0.00001, 0 issued and outstanding as of March 31, 2019 and December 31, 2018, respectively
Common stock, 50,000,000 shares authorized, par value $0.00001, 12,191,508 and 11,708,041 issued and outstanding as of March 31, 2019 and December 31, 2018, respectively 122 117
Additional paid-in capital 23,064,096 21,857,017
Subscription receivable - related party (7,447) (7,447)
Accumulated deficit (18,194,355) (16,496,757)
Total stockholders' equity 4,862,416 5,352,930
Total liabilities and stockholders' equity $ 6,988,694 $ 7,397,547